Oxford Biomedica plc (OXBDF)
OTCMKTS · Delayed Price · Currency is USD
11.34
+0.09 (0.78%)
At close: Feb 11, 2026

Oxford Biomedica Statistics

Total Valuation

OXBDF has a market cap or net worth of 1.35 billion. The enterprise value is 1.42 billion.

Market Cap1.35B
Enterprise Value 1.42B

Important Dates

The next estimated earnings date is Thursday, April 9, 2026.

Earnings Date Apr 9, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 120.83M
Shares Outstanding n/a
Shares Change (YoY) +2.96%
Shares Change (QoQ) +4.23%
Owned by Insiders (%) 1.84%
Owned by Institutions (%) 46.27%
Float 67.56M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 6.49
PB Ratio 30.00
P/TBV Ratio 116.74
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -27.88
EV / Sales 6.86
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -85.90

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 3.22.

Current Ratio 1.89
Quick Ratio 1.59
Debt / Equity 3.22
Debt / EBITDA n/a
Debt / FCF -8.76
Interest Coverage -2.28

Financial Efficiency

Return on equity (ROE) is -75.20% and return on invested capital (ROIC) is -32.56%.

Return on Equity (ROE) -75.20%
Return on Assets (ROA) -7.44%
Return on Invested Capital (ROIC) -32.56%
Return on Capital Employed (ROCE) -18.72%
Weighted Average Cost of Capital (WACC) 10.28%
Revenue Per Employee 230,190
Profits Per Employee -56,423
Employee Count900
Asset Turnover 0.66
Inventory Turnover 5.25

Taxes

In the past 12 months, OXBDF has paid 2.09 million in taxes.

Income Tax 2.09M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +125.10% in the last 52 weeks. The beta is 1.12, so OXBDF's price volatility has been higher than the market average.

Beta (5Y) 1.12
52-Week Price Change +125.10%
50-Day Moving Average 8.17
200-Day Moving Average 5.00
Relative Strength Index (RSI) 69.93
Average Volume (20 Days) 11,197

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, OXBDF had revenue of 207.17 million and -50.78 million in losses. Loss per share was -0.49.

Revenue207.17M
Gross Profit 91.41M
Operating Income -37.60M
Pretax Income -51.46M
Net Income -50.78M
EBITDA -17.22M
EBIT -37.60M
Loss Per Share -0.49
Full Income Statement

Balance Sheet

The company has 73.81 million in cash and 144.44 million in debt, with a net cash position of -70.62 million.

Cash & Cash Equivalents 73.81M
Total Debt 144.44M
Net Cash -70.62M
Net Cash Per Share n/a
Equity (Book Value) 44.84M
Book Value Per Share 0.42
Working Capital 85.04M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.74 million and capital expenditures -5.74 million, giving a free cash flow of -16.48 million.

Operating Cash Flow -10.74M
Capital Expenditures -5.74M
Free Cash Flow -16.48M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 44.12%, with operating and profit margins of -18.15% and -24.51%.

Gross Margin 44.12%
Operating Margin -18.15%
Pretax Margin -24.84%
Profit Margin -24.51%
EBITDA Margin -8.31%
EBIT Margin -18.15%
FCF Margin n/a

Dividends & Yields

OXBDF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.96%
Shareholder Yield -2.96%
Earnings Yield -3.77%
FCF Yield -1.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

OXBDF has an Altman Z-Score of -0.87 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.87
Piotroski F-Score 4